Change in the Management of TSS

The TSS company logo, representing a change in the company's management.
We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.

After 16 years of dedicated service as our Chief Executive Officer (CEO), Niclas Ohlsson has made the decision to step down to prioritize his well-being following a recent health scare. Niclas has been instrumental in shaping TSS into a leading company within the industry, and we are truly grateful for his years of hard work and leadership.

Stepping into the role of CEO is Tobias Holmer, our CTO for the past 9 years and interim CEO for the last 7 months. Tobias's wealth of experience and forward-thinking leadership have already positively impacted our organization, and we are enthusiastic about the exciting future under his guidance.

We are excited to continue our mission of delivering the highest standards in temperature monitoring solutions for the pharmaceutical industry.

Join us in wishing Niclas all the best in his future endeavors and thanking him for his remarkable contributions. Here’s to a new era of growth and success with Tobias at the helm!

__wf_reserved_inherit
Tobias Holmer, CEO

You may also be interested in

Responsible Minerals Sourcing Policy

Read moreDownload Whitepaper

Innovation flourishes when different perspectives meet

Moving to Stockholm’s new innovation and life science cluster in Hagastaden was a conscious choice for us at TSS.
Read moreDownload Whitepaper
A futuristic, digital illustration of a pipette adding a drop of liquid to test tubes, representing advanced technology in clinical trial management.

Boost value in clinical trial management with two-way integrations

Two-way integrations between IRT and the temperature system unlock cold chain consistency in clinical development – protecting patients, maximizing value and minimizing operational costs.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.